DGX - Quest Diagnostics Inc Stock Price, Fair Value and News

$161.99+0.55 (+0.34%)

Delayed as of 03 Dec 2024, 12:28 pm ET

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

DGX Price Action

Last 7 days

-0.6%

Last 30 days

4.0%

Last 90 days

2.9%

Trailing 12 Months

18.6%

DGX RSI Chart

DGX Valuation

Market Cap

18.1B

Price/Earnings (Trailing)

21.5

Price/Sales (Trailing)

1.9

EV/EBITDA

16.36

Price/Free Cashflow

17.67

DGX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

DGX Fundamentals

DGX Revenue

Revenue (TTM)

9.5B

Rev. Growth (Yr)

8.41%

Rev. Growth (Qtr)

3.8%

DGX Earnings

Earnings (TTM)

841.0M

Earnings Growth (Yr)

0.44%

Earnings Growth (Qtr)

-1.31%

DGX Profitability

Operating Margin

32.73%

EBT Margin

11.67%

Return on Equity

12.35%

Return on Assets

5.23%

Free Cashflow Yield

5.66%

DGX Investor Care

Dividend Yield

1.83%

Dividend/Share (TTM)

2.96

Diluted EPS (TTM)

7.44

DGX Alerts

4 major insider sales recently.

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	9.3B	9.3B	9.5B	0
2023	9.6B	9.5B	9.3B	9.3B
2022	10.7B	10.6B	10.3B	9.9B
2021	10.3B	11.1B	11.0B	10.8B
2020	7.7B	7.5B	8.4B	9.4B
2019	7.5B	7.6B	7.6B	7.7B
2018	7.5B	7.5B	7.6B	7.5B
2017	7.5B	7.4B	7.4B	7.4B
2016	7.5B	7.5B	7.5B	7.5B
2015	7.5B	7.6B	7.5B	7.5B
2014	7.2B	7.3B	7.4B	7.4B
2013	7.3B	7.2B	7.2B	7.1B
2012	7.5B	7.5B	7.5B	7.4B
2011	7.4B	7.4B	7.4B	7.4B
2010	7.5B	7.4B	7.4B	7.4B

Get all data in R, Python etc through our Historical Stock Data APIs

About Quest Diagnostics Inc

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

CEO	Mr. James E. Davis
WEBSITE	questdiagnostics.com
SECTOR	Healthcare
INDUSTRY	Diagnostics & Research
EMPLOYEES	40000

Quest Diagnostics Inc Frequently Asked Questions

What is the ticker symbol for Quest Diagnostics Inc? What does DGX stand for in stocks?

DGX is the stock ticker symbol of Quest Diagnostics Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Quest Diagnostics Inc (DGX)?

As of Mon Dec 02 2024, market cap of Quest Diagnostics Inc is 18.08 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of DGX stock?

You can check DGX's fair value in chart for subscribers.

Is Quest Diagnostics Inc a good stock to buy?

The fair value guage provides a quick view whether DGX is over valued or under valued. Whether Quest Diagnostics Inc is cheap or expensive depends on the assumptions which impact Quest Diagnostics Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for DGX.

What is Quest Diagnostics Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Dec 02 2024, DGX's PE ratio (Price to Earnings) is 21.5 and Price to Sales (PS) ratio is 1.9. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DGX PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Quest Diagnostics Inc's stock?

In the past 10 years, Quest Diagnostics Inc has provided 0.095 (multiply by 100 for percentage) rate of return.